Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Charles L. Anzalone"'
Autor:
Jamie J. Van Gompel, Charles L. Anzalone, Matthew L. Carlson, Amy E. Glasgow, Brandon R. Grossard, Elizabeth B. Habermann
Publikováno v:
J Neurol Surg B Skull Base
Background Age, tumor size and location, overall health, and patient preference are primary considerations driving treatment decision-making for intracranial meningiomas. However, even for the same individual patient, treatment recommendations may va
Autor:
Charles L. Anzalone, Mai-Lan Ho, Matthew L. Carlson, Lisa A. Schimmenti, Melissa D. DeJong, Neil S. Patel
Publikováno v:
Otologyneurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 38(5)
Objective To describe a novel case of congenital profound bilateral sensorineural hearing loss in a patient with bilateral nodular internal auditory canal and labyrinthine enhancement and temporal bone dysplasia. Patients A 76-day-old female was refe
Publikováno v:
Otologyneurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 38(5)
OBJECTIVE To describe a unique case of an asymptomatic arteriovenous lesion of the internal auditory canal (IAC) and present the associated imaging findings. METHODS Retrospective case report and review of the literature. RESULTS A 55-year-old man pr
Publikováno v:
International journal of dermatology. 52(7)
Background Mohs micrographic surgery is the reference standard treatment for primary cutaneous malignancies. Objectives The purpose of this case study is to demonstrate that Mohs surgery may be considered as a possible treatment for a solitary metast
Autor:
Charles L. Anzalone, Philip R. Cohen
Publikováno v:
Current opinion in hematology. 20(1)
To highlight the recent observations regarding not only research but also the clinical features and management of Sweet's syndrome.Some of the new insights concerning Sweet's syndrome include: (1) bortezomib-induced Sweet's syndrome (some of which ar